

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 8.21346276 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.91201260 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.91201260 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.73345505 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.73345505 |
| 6 | NADH metabolic process (GO:0006734) | 6.54255648 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.18621555 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.77751353 |
| 9 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.76486999 |
| 10 | regulation of guanylate cyclase activity (GO:0031282) | 5.67187789 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.54178979 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.54178979 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.54178979 |
| 14 | urea cycle (GO:0000050) | 5.51744330 |
| 15 | urea metabolic process (GO:0019627) | 5.51744330 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.51078783 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.45684760 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.40914098 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.37837022 |
| 20 | cysteine metabolic process (GO:0006534) | 5.36330119 |
| 21 | glyoxylate metabolic process (GO:0046487) | 5.32797555 |
| 22 | homocysteine metabolic process (GO:0050667) | 5.28469017 |
| 23 | intestinal absorption (GO:0050892) | 5.25692044 |
| 24 | tryptophan metabolic process (GO:0006568) | 5.23267492 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.06078134 |
| 26 | lysine metabolic process (GO:0006553) | 5.04341662 |
| 27 | lysine catabolic process (GO:0006554) | 5.04341662 |
| 28 | lipoprotein transport (GO:0042953) | 5.04177637 |
| 29 | protein carboxylation (GO:0018214) | 4.92395878 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.92395878 |
| 31 | negative regulation of fibrinolysis (GO:0051918) | 4.91433705 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 4.90148923 |
| 33 | fructose metabolic process (GO:0006000) | 4.87055593 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 4.74491321 |
| 35 | regulation of protein activation cascade (GO:2000257) | 4.73921362 |
| 36 | complement activation, alternative pathway (GO:0006957) | 4.73270855 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.67073225 |
| 38 | regulation of fibrinolysis (GO:0051917) | 4.66679495 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.58588001 |
| 40 | bile acid metabolic process (GO:0008206) | 4.57853112 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 4.57260426 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.55863082 |
| 43 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.53041142 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.50825225 |
| 45 | regulation of complement activation (GO:0030449) | 4.47454670 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 4.42920658 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.42375007 |
| 48 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.40974970 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.35636228 |
| 50 | reverse cholesterol transport (GO:0043691) | 4.35578561 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.35000590 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.35000590 |
| 53 | cellular glucuronidation (GO:0052695) | 4.27036749 |
| 54 | ethanol oxidation (GO:0006069) | 4.24713880 |
| 55 | plasma lipoprotein particle remodeling (GO:0034369) | 4.24169592 |
| 56 | protein-lipid complex remodeling (GO:0034368) | 4.24169592 |
| 57 | macromolecular complex remodeling (GO:0034367) | 4.24169592 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.19790745 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.19790745 |
| 60 | glycine metabolic process (GO:0006544) | 4.16417752 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.13825298 |
| 62 | hormone catabolic process (GO:0042447) | 4.13074288 |
| 63 | serine family amino acid biosynthetic process (GO:0009070) | 4.08109827 |
| 64 | serine family amino acid metabolic process (GO:0009069) | 4.06754884 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 4.02671799 |
| 66 | glutamate metabolic process (GO:0006536) | 4.01616077 |
| 67 | COPI coating of Golgi vesicle (GO:0048205) | 3.98267424 |
| 68 | Golgi transport vesicle coating (GO:0048200) | 3.98267424 |
| 69 | bile acid and bile salt transport (GO:0015721) | 3.98224107 |
| 70 | coenzyme catabolic process (GO:0009109) | 3.96930651 |
| 71 | ketone body metabolic process (GO:1902224) | 3.94352701 |
| 72 | phospholipid efflux (GO:0033700) | 3.93974580 |
| 73 | aldehyde catabolic process (GO:0046185) | 3.92545186 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 3.92439459 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 3.91800764 |
| 76 | COPII vesicle coating (GO:0048208) | 3.89905931 |
| 77 | epoxygenase P450 pathway (GO:0019373) | 3.89116086 |
| 78 | arginine metabolic process (GO:0006525) | 3.86680226 |
| 79 | indolalkylamine metabolic process (GO:0006586) | 3.86572176 |
| 80 | drug catabolic process (GO:0042737) | 3.86342709 |
| 81 | glucuronate metabolic process (GO:0019585) | 3.85443273 |
| 82 | uronic acid metabolic process (GO:0006063) | 3.85443273 |
| 83 | short-chain fatty acid metabolic process (GO:0046459) | 3.85032751 |
| 84 | ethanol metabolic process (GO:0006067) | 3.79927923 |
| 85 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79079860 |
| 86 | aspartate family amino acid catabolic process (GO:0009068) | 3.78386707 |
| 87 | amine catabolic process (GO:0009310) | 3.76315181 |
| 88 | cellular biogenic amine catabolic process (GO:0042402) | 3.76315181 |
| 89 | imidazole-containing compound metabolic process (GO:0052803) | 3.75078027 |
| 90 | cholesterol efflux (GO:0033344) | 3.74034531 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.72681950 |
| 92 | 2-oxoglutarate metabolic process (GO:0006103) | 3.72123621 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 3.70832844 |
| 94 | plasma lipoprotein particle assembly (GO:0034377) | 3.70507873 |
| 95 | protein-lipid complex assembly (GO:0065005) | 3.69596445 |
| 96 | carboxylic acid catabolic process (GO:0046395) | 3.68991739 |
| 97 | organic acid catabolic process (GO:0016054) | 3.68991739 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 3.68312236 |
| 99 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.64420741 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.62268114 |
| 101 | response to nitrosative stress (GO:0051409) | 3.61895687 |
| 102 | fatty acid beta-oxidation (GO:0006635) | 3.59652888 |
| 103 | low-density lipoprotein particle remodeling (GO:0034374) | 3.59307610 |
| 104 | flavonoid metabolic process (GO:0009812) | 3.59287850 |
| 105 | fibrinolysis (GO:0042730) | 3.57508529 |
| 106 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.56985957 |
| 107 | primary alcohol catabolic process (GO:0034310) | 3.54583489 |
| 108 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.53548439 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 3.53307409 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.53223065 |
| 111 | fatty acid oxidation (GO:0019395) | 3.51203029 |
| 112 | monocarboxylic acid catabolic process (GO:0072329) | 3.50538944 |
| 113 | carnitine metabolic process (GO:0009437) | 3.48723201 |
| 114 | cofactor catabolic process (GO:0051187) | 3.48705104 |
| 115 | vitamin transmembrane transport (GO:0035461) | 3.48154684 |
| 116 | phospholipid homeostasis (GO:0055091) | 3.48114604 |
| 117 | sterol homeostasis (GO:0055092) | 3.47745040 |
| 118 | drug metabolic process (GO:0017144) | 3.47000917 |
| 119 | adhesion of symbiont to host cell (GO:0044650) | 3.45357933 |
| 120 | virion attachment to host cell (GO:0019062) | 3.45357933 |
| 121 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.45318840 |
| 122 | endocrine process (GO:0050886) | 3.45318840 |
| 123 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.45318840 |
| 124 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.44375580 |
| 125 | tricarboxylic acid cycle (GO:0006099) | 3.37636491 |
| 126 | regulation of systemic arterial blood pressure (GO:0003073) | 3.36798915 |
| 127 | peptide hormone processing (GO:0016486) | 3.31177383 |
| 128 | transcytosis (GO:0045056) | 3.31077285 |
| 129 | renal system process involved in regulation of blood volume (GO:0001977) | 3.30972542 |
| 130 | vitamin A metabolic process (GO:0006776) | 3.29761369 |
| 131 | sphingomyelin metabolic process (GO:0006684) | 3.28826880 |
| 132 | positive regulation of pseudopodium assembly (GO:0031274) | 3.24670096 |
| 133 | regulation of cGMP biosynthetic process (GO:0030826) | 3.24031589 |
| 134 | L-ascorbic acid metabolic process (GO:0019852) | 3.23709708 |
| 135 | cellular response to oxygen radical (GO:0071450) | 3.14144548 |
| 136 | removal of superoxide radicals (GO:0019430) | 3.14144548 |
| 137 | cellular response to superoxide (GO:0071451) | 3.14144548 |
| 138 | glycosphingolipid catabolic process (GO:0046479) | 3.08239038 |
| 139 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.06233364 |
| 140 | glycolipid catabolic process (GO:0019377) | 3.05228662 |
| 141 | glycosylceramide metabolic process (GO:0006677) | 3.01722492 |
| 142 | oxaloacetate metabolic process (GO:0006107) | 3.00238577 |
| 143 | digestion (GO:0007586) | 2.98350592 |
| 144 | vitamin transport (GO:0051180) | 2.96512532 |
| 145 | zinc ion transport (GO:0006829) | 2.94908668 |
| 146 | * glutamine family amino acid biosynthetic process (GO:0009084) | 2.94689824 |
| 147 | heme transport (GO:0015886) | 2.93987200 |
| 148 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.93732424 |
| 149 | ribosome assembly (GO:0042255) | 2.93536093 |
| 150 | drinking behavior (GO:0042756) | 2.92589082 |
| 151 | cellular response to nitric oxide (GO:0071732) | 2.92472258 |
| 152 | vitamin biosynthetic process (GO:0009110) | 2.91994492 |
| 153 | proteasome assembly (GO:0043248) | 2.89086807 |
| 154 | cobalamin metabolic process (GO:0009235) | 2.88880619 |
| 155 | lipoprotein metabolic process (GO:0042157) | 2.86258599 |
| 156 | sphingolipid catabolic process (GO:0030149) | 2.85769391 |
| 157 | fat-soluble vitamin metabolic process (GO:0006775) | 2.85356147 |
| 158 | adhesion of symbiont to host (GO:0044406) | 2.83323315 |
| 159 | regulation of pseudopodium assembly (GO:0031272) | 2.83171295 |
| 160 | midgut development (GO:0007494) | 2.81857576 |
| 161 | peptide catabolic process (GO:0043171) | 2.79623119 |
| 162 | diacylglycerol metabolic process (GO:0046339) | 2.78671689 |
| 163 | desmosome organization (GO:0002934) | 2.76261509 |
| 164 | urate metabolic process (GO:0046415) | 2.71622224 |
| 165 | regulation of cGMP metabolic process (GO:0030823) | 2.69939710 |
| 166 | membrane lipid catabolic process (GO:0046466) | 2.69790582 |
| 167 | regulation of vitamin metabolic process (GO:0030656) | 2.69365616 |
| 168 | glycoside metabolic process (GO:0016137) | 2.68479224 |
| 169 | regulation of cellular extravasation (GO:0002691) | 2.68282388 |
| 170 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.68089541 |
| 171 | glycerol metabolic process (GO:0006071) | 2.65425064 |
| 172 | neutral amino acid transport (GO:0015804) | 2.62051992 |
| 173 | ceramide catabolic process (GO:0046514) | 2.60903280 |
| 174 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.60174896 |
| 175 | regulation of protein glycosylation (GO:0060049) | 2.60125977 |
| 176 | cyclooxygenase pathway (GO:0019371) | 2.59430711 |
| 177 | actin filament depolymerization (GO:0030042) | 2.58513177 |
| 178 | negative regulation of steroid biosynthetic process (GO:0010894) | 2.57537575 |
| 179 | very long-chain fatty acid metabolic process (GO:0000038) | 2.56115102 |
| 180 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.56110703 |
| 181 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.54647173 |
| 182 | antibacterial humoral response (GO:0019731) | 2.54102992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.78800966 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.85780628 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.11195639 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.08440250 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.75803392 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.70394425 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.66381996 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.62524852 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.56710600 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.48342065 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.91502810 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.51776582 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.47706208 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.45921386 |
| 15 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.19122757 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.09443056 |
| 17 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.01171428 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2817036 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.99947666 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.86902905 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.86302485 |
| 22 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.85426131 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.77231372 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76513902 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74014173 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.72503057 |
| 27 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.67343046 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59894511 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52101928 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.50407426 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.49874556 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.47518073 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47355970 |
| 34 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.46064108 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.40899180 |
| 36 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.40508384 |
| 37 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.37026808 |
| 38 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35894310 |
| 39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35446085 |
| 40 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34503198 |
| 41 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.33582363 |
| 42 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.32264009 |
| 43 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.28618856 |
| 44 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.26945315 |
| 45 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.26820849 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26145548 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.24935778 |
| 48 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20872022 |
| 49 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 1.19597331 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.19570621 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17030525 |
| 52 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15084911 |
| 53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14102291 |
| 54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13491048 |
| 55 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.13324772 |
| 56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11454802 |
| 57 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.11103049 |
| 58 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.11099476 |
| 59 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10408204 |
| 60 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09759057 |
| 61 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09759057 |
| 62 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07453192 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06802072 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.05451914 |
| 65 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05420648 |
| 66 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.05221001 |
| 67 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.04721722 |
| 68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03632729 |
| 69 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.02325545 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02283371 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01392970 |
| 72 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01349078 |
| 73 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.00646130 |
| 74 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.00201665 |
| 75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98388844 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96927384 |
| 77 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.96500282 |
| 78 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96153622 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94818500 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94784644 |
| 81 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.94305826 |
| 82 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92270487 |
| 83 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.91938374 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91503571 |
| 85 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.90783935 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90430843 |
| 87 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.89028319 |
| 88 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.88536335 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87554786 |
| 90 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87034316 |
| 91 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.86518547 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86481389 |
| 93 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.86381315 |
| 94 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.85776853 |
| 95 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.85721791 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85328936 |
| 97 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85145628 |
| 98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84222313 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.83560010 |
| 100 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.82895498 |
| 101 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.82390974 |
| 102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80659575 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79029589 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78825354 |
| 105 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77842695 |
| 106 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77842695 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77758811 |
| 108 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77357392 |
| 109 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.76937470 |
| 110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72962886 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.72860601 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72761265 |
| 113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72266279 |
| 114 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68492474 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65951348 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65788742 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64857828 |
| 118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63467886 |
| 119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.60968364 |
| 120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.60581976 |
| 121 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.59198114 |
| 122 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58793482 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58771264 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.57899288 |
| 125 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.57703275 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57306405 |
| 127 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.56847797 |
| 128 | ATF3_27146783_Chip-Seq_COLON_Human | 0.56636987 |
| 129 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55350154 |
| 130 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55177747 |
| 131 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55115444 |
| 132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.53855866 |
| 133 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.53855866 |
| 134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52864367 |
| 135 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.52581130 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52267055 |
| 137 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.52184282 |
| 138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.51804628 |
| 139 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.51715029 |
| 140 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.50611367 |
| 141 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.49987410 |
| 142 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.48306060 |
| 143 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46575960 |
| 144 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45788920 |
| 145 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.45406085 |
| 146 | GATA2_19941826_ChIP-Seq_K562_Human | 0.45390960 |
| 147 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.45352325 |
| 148 | CJUN_26792858_Chip-Seq_BT549_Human | 0.45256179 |
| 149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.44695087 |
| 150 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.44006423 |
| 151 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.43040899 |
| 152 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42997194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.76145302 |
| 2 | MP0005360_urolithiasis | 7.35614812 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.93656186 |
| 4 | MP0005365_abnormal_bile_salt | 5.55507646 |
| 5 | MP0004147_increased_porphyrin_level | 5.13177657 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93912698 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.19860307 |
| 8 | MP0003252_abnormal_bile_duct | 3.64445599 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.33213782 |
| 10 | MP0004264_abnormal_extraembryonic_tissu | 3.24839821 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 3.20068159 |
| 12 | MP0009840_abnormal_foam_cell | 3.12966874 |
| 13 | MP0005083_abnormal_biliary_tract | 2.83366406 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.73629760 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.72673465 |
| 16 | * MP0005332_abnormal_amino_acid | 2.69119134 |
| 17 | MP0003718_maternal_effect | 2.68370659 |
| 18 | MP0003195_calcinosis | 2.48508264 |
| 19 | MP0003941_abnormal_skin_development | 2.26813760 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.12191260 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.10863405 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 1.99765618 |
| 23 | MP0000609_abnormal_liver_physiology | 1.98063984 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.94650512 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.93074207 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.79897729 |
| 27 | MP0004957_abnormal_blastocyst_morpholog | 1.75807383 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.72594177 |
| 29 | MP0003693_abnormal_embryo_hatching | 1.65815368 |
| 30 | MP0001188_hyperpigmentation | 1.64793087 |
| 31 | MP0003186_abnormal_redox_activity | 1.57228118 |
| 32 | MP0001764_abnormal_homeostasis | 1.54138524 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53579901 |
| 34 | MP0005409_darkened_coat_color | 1.52144735 |
| 35 | MP0003868_abnormal_feces_composition | 1.51301918 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.47355891 |
| 37 | MP0004272_abnormal_basement_membrane | 1.45585435 |
| 38 | MP0001664_abnormal_digestion | 1.36691758 |
| 39 | MP0003011_delayed_dark_adaptation | 1.34681055 |
| 40 | * MP0009643_abnormal_urine_homeostasis | 1.34634801 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.30089288 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.26676582 |
| 43 | MP0009697_abnormal_copulation | 1.26094479 |
| 44 | MP0004270_analgesia | 1.25555418 |
| 45 | MP0000462_abnormal_digestive_system | 1.25172993 |
| 46 | MP0001881_abnormal_mammary_gland | 1.22530218 |
| 47 | MP0005501_abnormal_skin_physiology | 1.21108337 |
| 48 | MP0002254_reproductive_system_inflammat | 1.19494577 |
| 49 | MP0005451_abnormal_body_composition | 1.14504881 |
| 50 | MP0008438_abnormal_cutaneous_collagen | 1.12654253 |
| 51 | MP0000537_abnormal_urethra_morphology | 1.12158847 |
| 52 | MP0000598_abnormal_liver_morphology | 1.11607123 |
| 53 | MP0005408_hypopigmentation | 1.09170842 |
| 54 | MP0009384_cardiac_valve_regurgitation | 1.08887829 |
| 55 | MP0009764_decreased_sensitivity_to | 1.07485848 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.03472237 |
| 57 | MP0000490_abnormal_crypts_of | 1.01401080 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 0.97578199 |
| 59 | MP0005647_abnormal_sex_gland | 0.97295616 |
| 60 | MP0000477_abnormal_intestine_morphology | 0.95819514 |
| 61 | MP0010368_abnormal_lymphatic_system | 0.95709008 |
| 62 | MP0002098_abnormal_vibrissa_morphology | 0.94408240 |
| 63 | MP0008932_abnormal_embryonic_tissue | 0.93206426 |
| 64 | MP0000604_amyloidosis | 0.93179142 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 0.93153389 |
| 66 | MP0000516_abnormal_urinary_system | 0.91895105 |
| 67 | MP0005367_renal/urinary_system_phenotyp | 0.91895105 |
| 68 | MP0009763_increased_sensitivity_to | 0.91877046 |
| 69 | MP0004130_abnormal_muscle_cell | 0.90255070 |
| 70 | MP0010307_abnormal_tumor_latency | 0.87380865 |
| 71 | MP0008469_abnormal_protein_level | 0.81992608 |
| 72 | MP0010678_abnormal_skin_adnexa | 0.81781421 |
| 73 | MP0005376_homeostasis/metabolism_phenot | 0.80862828 |
| 74 | MP0005257_abnormal_intraocular_pressure | 0.80441276 |
| 75 | MP0001765_abnormal_ion_homeostasis | 0.79205225 |
| 76 | * MP0009642_abnormal_blood_homeostasis | 0.79059685 |
| 77 | MP0001756_abnormal_urination | 0.78308868 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 0.77609404 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 0.74064538 |
| 80 | MP0008260_abnormal_autophagy | 0.73954290 |
| 81 | MP0005670_abnormal_white_adipose | 0.73487956 |
| 82 | MP0000427_abnormal_hair_cycle | 0.72414349 |
| 83 | MP0001730_embryonic_growth_arrest | 0.72235956 |
| 84 | MP0005275_abnormal_skin_tensile | 0.72209790 |
| 85 | MP0009053_abnormal_anal_canal | 0.71169484 |
| 86 | MP0000762_abnormal_tongue_morphology | 0.70435443 |
| 87 | MP0002896_abnormal_bone_mineralization | 0.69332525 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.69121366 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.69112603 |
| 90 | MP0001216_abnormal_epidermal_layer | 0.68728587 |
| 91 | MP0002971_abnormal_brown_adipose | 0.67772736 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 0.67276477 |
| 93 | MP0003111_abnormal_nucleus_morphology | 0.66692923 |
| 94 | MP0000627_abnormal_mammary_gland | 0.65786876 |
| 95 | MP0000467_abnormal_esophagus_morphology | 0.65667065 |
| 96 | MP0005266_abnormal_metabolism | 0.63261042 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.63254767 |
| 98 | MP0003300_gastrointestinal_ulcer | 0.63097552 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.63042462 |
| 100 | MP0003315_abnormal_perineum_morphology | 0.61863334 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.61271829 |
| 102 | MP0003724_increased_susceptibility_to | 0.59748220 |
| 103 | MP0010234_abnormal_vibrissa_follicle | 0.59205646 |
| 104 | MP0003690_abnormal_glial_cell | 0.59193995 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.58743705 |
| 106 | MP0002060_abnormal_skin_morphology | 0.58052963 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.57713917 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.57683886 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.57442259 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.57173378 |
| 111 | MP0003786_premature_aging | 0.56002548 |
| 112 | MP0005334_abnormal_fat_pad | 0.54649763 |
| 113 | MP0008058_abnormal_DNA_repair | 0.54007844 |
| 114 | MP0003329_amyloid_beta_deposits | 0.53737694 |
| 115 | MP0010771_integument_phenotype | 0.53729933 |
| 116 | MP0005174_abnormal_tail_pigmentation | 0.53649564 |
| 117 | MP0001243_abnormal_dermal_layer | 0.52681382 |
| 118 | MP0005166_decreased_susceptibility_to | 0.52538263 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.51456909 |
| 120 | MP0000377_abnormal_hair_follicle | 0.51106064 |
| 121 | MP0005023_abnormal_wound_healing | 0.50748498 |
| 122 | MP0003279_aneurysm | 0.49954419 |
| 123 | MP0008004_abnormal_stomach_pH | 0.49686859 |
| 124 | MP0006054_spinal_hemorrhage | 0.49672431 |
| 125 | MP0004215_abnormal_myocardial_fiber | 0.48467618 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 0.48364839 |
| 127 | MP0009379_abnormal_foot_pigmentation | 0.47545670 |
| 128 | MP0005535_abnormal_body_temperature | 0.47394849 |
| 129 | MP0001191_abnormal_skin_condition | 0.47328371 |
| 130 | MP0002938_white_spotting | 0.46985806 |
| 131 | MP0001661_extended_life_span | 0.46495980 |
| 132 | MP0001853_heart_inflammation | 0.46458982 |
| 133 | MP0001485_abnormal_pinna_reflex | 0.46024698 |
| 134 | MP0005448_abnormal_energy_balance | 0.45672828 |
| 135 | MP0008007_abnormal_cellular_replicative | 0.45556942 |
| 136 | MP0003075_altered_response_to | 0.45058491 |
| 137 | MP0005164_abnormal_response_to | 0.44692765 |
| 138 | MP0002796_impaired_skin_barrier | 0.44124255 |
| 139 | MP0001958_emphysema | 0.43543802 |
| 140 | MP0005058_abnormal_lysosome_morphology | 0.42797346 |
| 141 | MP0002132_abnormal_respiratory_system | 0.42661215 |
| 142 | MP0000639_abnormal_adrenal_gland | 0.42145134 |
| 143 | MP0000230_abnormal_systemic_arterial | 0.42031030 |
| 144 | MP0008872_abnormal_physiological_respon | 0.41455285 |
| 145 | MP0004043_abnormal_pH_regulation | 0.41403496 |
| 146 | MP0004883_abnormal_blood_vessel | 0.41235480 |
| 147 | MP0005395_other_phenotype | 0.40874511 |
| 148 | MP0000249_abnormal_blood_vessel | 0.40423746 |
| 149 | MP0008873_increased_physiological_sensi | 0.39463343 |
| 150 | MP0001873_stomach_inflammation | 0.37833279 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.36301782 |
| 152 | MP0005165_increased_susceptibility_to | 0.35936662 |
| 153 | MP0005330_cardiomyopathy | 0.35523964 |
| 154 | MP0000538_abnormal_urinary_bladder | 0.35401145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.63315193 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.58482237 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.49268537 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.25787869 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.89357347 |
| 6 | Xanthomatosis (HP:0000991) | 5.89296399 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.38209622 |
| 8 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.89102233 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.85708058 |
| 10 | Hyperammonemia (HP:0001987) | 4.85364064 |
| 11 | Abnormality of vitamin B metabolism (HP:0004340) | 4.67697384 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.62298774 |
| 13 | Complement deficiency (HP:0004431) | 4.57674022 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.48558485 |
| 15 | Ketosis (HP:0001946) | 4.35067479 |
| 16 | Epidermoid cyst (HP:0200040) | 4.13843451 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.13280659 |
| 18 | Hyperglycinuria (HP:0003108) | 4.11683124 |
| 19 | Hyperglycinemia (HP:0002154) | 4.06146647 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.04456074 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.04413342 |
| 22 | Confusion (HP:0001289) | 4.04100201 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.00100700 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.00100700 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.92605475 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.92369266 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.91385092 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.79861038 |
| 29 | Fat malabsorption (HP:0002630) | 3.76071277 |
| 30 | Joint hemorrhage (HP:0005261) | 3.75493674 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.68275142 |
| 32 | Megaloblastic anemia (HP:0001889) | 3.65901754 |
| 33 | Ketoacidosis (HP:0001993) | 3.54270847 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.46534264 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.45405152 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.45363797 |
| 37 | Abnormality of complement system (HP:0005339) | 3.38810133 |
| 38 | Patchy hypopigmentation of hair (HP:0011365) | 3.32874728 |
| 39 | Chronic diarrhea (HP:0002028) | 3.30098490 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.27640001 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.18596689 |
| 42 | White forelock (HP:0002211) | 3.18256295 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.15329454 |
| 44 | Widely patent fontanelles and sutures (HP:0004492) | 3.15108570 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07589477 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.01218857 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 2.99003313 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.91481345 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.88117084 |
| 50 | Metabolic acidosis (HP:0001942) | 2.84743695 |
| 51 | Pili torti (HP:0003777) | 2.84454295 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82360291 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.82360291 |
| 54 | Lethargy (HP:0001254) | 2.79782518 |
| 55 | Abnormality of glycolysis (HP:0004366) | 2.78360448 |
| 56 | Increased serum pyruvate (HP:0003542) | 2.77904179 |
| 57 | Gout (HP:0001997) | 2.75612375 |
| 58 | Steatorrhea (HP:0002570) | 2.72851356 |
| 59 | Symptomatic seizures (HP:0011145) | 2.72510697 |
| 60 | Myocardial infarction (HP:0001658) | 2.71257282 |
| 61 | Skin nodule (HP:0200036) | 2.70255335 |
| 62 | Cerebral edema (HP:0002181) | 2.68568770 |
| 63 | Spastic diplegia (HP:0001264) | 2.65063605 |
| 64 | Wide cranial sutures (HP:0010537) | 2.56349900 |
| 65 | Nephrolithiasis (HP:0000787) | 2.56077349 |
| 66 | Spontaneous abortion (HP:0005268) | 2.44804234 |
| 67 | Vascular calcification (HP:0004934) | 2.44090510 |
| 68 | Right ventricular cardiomyopathy (HP:0011663) | 2.43364364 |
| 69 | Malnutrition (HP:0004395) | 2.43023859 |
| 70 | Hydroxyprolinuria (HP:0003080) | 2.40979542 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.40979542 |
| 72 | Acanthocytosis (HP:0001927) | 2.39314327 |
| 73 | Late onset (HP:0003584) | 2.38353635 |
| 74 | Hyperphosphaturia (HP:0003109) | 2.37046494 |
| 75 | Cholelithiasis (HP:0001081) | 2.36791624 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.36780647 |
| 77 | Abnormal cartilage morphology (HP:0002763) | 2.36394176 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.36204928 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.32193465 |
| 80 | Vomiting (HP:0002013) | 2.27811540 |
| 81 | Mitral stenosis (HP:0001718) | 2.26834577 |
| 82 | Esophageal varix (HP:0002040) | 2.26702476 |
| 83 | Neonatal onset (HP:0003623) | 2.24276770 |
| 84 | Abnormal glucose tolerance (HP:0001952) | 2.23091220 |
| 85 | Generalized aminoaciduria (HP:0002909) | 2.22034032 |
| 86 | Hyperactive renin-angiotensin system (HP:0000841) | 2.19613144 |
| 87 | Abnormal urine phosphate concentration (HP:0012599) | 2.17958954 |
| 88 | Irritability (HP:0000737) | 2.16100992 |
| 89 | Alopecia of scalp (HP:0002293) | 2.15398298 |
| 90 | Abnormal gallbladder physiology (HP:0012438) | 2.14842606 |
| 91 | Cholecystitis (HP:0001082) | 2.14842606 |
| 92 | Abnormal hair laboratory examination (HP:0003328) | 2.12045041 |
| 93 | Pigmentary retinal degeneration (HP:0001146) | 2.10089360 |
| 94 | Amyloidosis (HP:0011034) | 2.09823872 |
| 95 | Ileus (HP:0002595) | 2.07394081 |
| 96 | Sensorimotor neuropathy (HP:0007141) | 2.07262176 |
| 97 | Proximal tubulopathy (HP:0000114) | 2.06600819 |
| 98 | Neoplasm of the small intestine (HP:0100833) | 2.06574561 |
| 99 | Neoplasm of the rectum (HP:0100743) | 2.06508697 |
| 100 | Abnormal biliary tract morphology (HP:0012440) | 2.05433385 |
| 101 | Increased purine levels (HP:0004368) | 2.04613056 |
| 102 | Hyperuricemia (HP:0002149) | 2.04613056 |
| 103 | Opisthotonus (HP:0002179) | 2.04237639 |
| 104 | Pancreatitis (HP:0001733) | 2.03742504 |
| 105 | Glomerulonephritis (HP:0000099) | 2.01662747 |
| 106 | Palpitations (HP:0001962) | 2.01275112 |
| 107 | Hypotension (HP:0002615) | 1.99605449 |
| 108 | Biliary tract neoplasm (HP:0100574) | 1.99031258 |
| 109 | Hyperparathyroidism (HP:0000843) | 1.97829033 |
| 110 | Premature rupture of membranes (HP:0001788) | 1.96836316 |
| 111 | Thin bony cortex (HP:0002753) | 1.96602238 |
| 112 | Hypoglycemic seizures (HP:0002173) | 1.96595641 |
| 113 | Alkalosis (HP:0001948) | 1.95789256 |
| 114 | Nausea (HP:0002018) | 1.94701031 |
| 115 | Abnormality of the gallbladder (HP:0005264) | 1.93173611 |
| 116 | Brushfield spots (HP:0001088) | 1.92371697 |
| 117 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.92037777 |
| 118 | Villous atrophy (HP:0011473) | 1.92037777 |
| 119 | Myoglobinuria (HP:0002913) | 1.91428035 |
| 120 | Abdominal distention (HP:0003270) | 1.90448454 |
| 121 | Glycosuria (HP:0003076) | 1.88981443 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 1.88981443 |
| 123 | Renal tubular acidosis (HP:0001947) | 1.86367564 |
| 124 | Renal tubular dysfunction (HP:0000124) | 1.84828415 |
| 125 | Hypochromic microcytic anemia (HP:0004840) | 1.83860201 |
| 126 | Enlarged kidneys (HP:0000105) | 1.83216183 |
| 127 | Thrombophlebitis (HP:0004418) | 1.83078572 |
| 128 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82810627 |
| 129 | Abnormality of the costochondral junction (HP:0000919) | 1.81614739 |
| 130 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.81398960 |
| 131 | Single umbilical artery (HP:0001195) | 1.81398960 |
| 132 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.81398960 |
| 133 | Respiratory distress (HP:0002098) | 1.81134115 |
| 134 | Abnormality of vitamin metabolism (HP:0100508) | 1.80972758 |
| 135 | Abnormality of magnesium homeostasis (HP:0004921) | 1.79971337 |
| 136 | Abnormality of iron homeostasis (HP:0011031) | 1.79084813 |
| 137 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.78119710 |
| 138 | Osteolytic defects of the hand bones (HP:0009699) | 1.78119710 |
| 139 | Poikilocytosis (HP:0004447) | 1.77549701 |
| 140 | Back pain (HP:0003418) | 1.77177160 |
| 141 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75998392 |
| 142 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75309698 |
| 143 | Elevated hepatic transaminases (HP:0002910) | 1.72369381 |
| 144 | Potter facies (HP:0002009) | 1.71704525 |
| 145 | Facial shape deformation (HP:0011334) | 1.71704525 |
| 146 | Hepatic necrosis (HP:0002605) | 1.71072920 |
| 147 | Hypophosphatemia (HP:0002148) | 1.70505995 |
| 148 | Hyperphosphatemia (HP:0002905) | 1.69507415 |
| 149 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.68395238 |
| 150 | Methylmalonic aciduria (HP:0012120) | 1.67096470 |
| 151 | Cerebral palsy (HP:0100021) | 1.67026649 |
| 152 | Chondrocalcinosis (HP:0000934) | 1.64145049 |
| 153 | Abnormality of the umbilical cord (HP:0010881) | 1.64073461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.09300308 |
| 2 | MST4 | 4.89503466 |
| 3 | ACVR1B | 4.64160690 |
| 4 | ERN1 | 4.03402024 |
| 5 | SIK1 | 3.78339229 |
| 6 | FGFR4 | 3.42636276 |
| 7 | LMTK2 | 3.26670623 |
| 8 | TRIB3 | 3.24321396 |
| 9 | PKN2 | 3.09966297 |
| 10 | MAP3K12 | 2.89930069 |
| 11 | MST1R | 2.88460125 |
| 12 | TSSK6 | 2.71268691 |
| 13 | EPHA2 | 2.60041362 |
| 14 | EIF2AK1 | 2.58436766 |
| 15 | BUB1 | 2.30783092 |
| 16 | EIF2AK3 | 2.30613496 |
| 17 | TTK | 2.10737985 |
| 18 | TRIM28 | 2.06325729 |
| 19 | FRK | 1.98136071 |
| 20 | BRSK2 | 1.95667281 |
| 21 | FLT3 | 1.94913802 |
| 22 | LATS1 | 1.84769047 |
| 23 | ERBB4 | 1.82262204 |
| 24 | WEE1 | 1.76629090 |
| 25 | PTK6 | 1.71825223 |
| 26 | TAOK3 | 1.61186619 |
| 27 | NEK9 | 1.61091282 |
| 28 | MAP3K3 | 1.60600058 |
| 29 | PIK3CG | 1.57270887 |
| 30 | STK39 | 1.51013169 |
| 31 | PDK4 | 1.50917539 |
| 32 | PDK3 | 1.50917539 |
| 33 | MYLK | 1.47649084 |
| 34 | ERBB3 | 1.45987411 |
| 35 | STK24 | 1.45820116 |
| 36 | PAK4 | 1.44298669 |
| 37 | SRPK1 | 1.43038003 |
| 38 | MAPK11 | 1.42499636 |
| 39 | OXSR1 | 1.37563924 |
| 40 | TTN | 1.36676753 |
| 41 | TYK2 | 1.31991501 |
| 42 | PLK3 | 1.31751947 |
| 43 | MET | 1.31497025 |
| 44 | INSRR | 1.27734758 |
| 45 | BRSK1 | 1.24402595 |
| 46 | FGFR2 | 1.23227361 |
| 47 | STK38L | 1.22363276 |
| 48 | MAP2K6 | 1.19745215 |
| 49 | MAP2K3 | 1.19592953 |
| 50 | ABL2 | 1.18974321 |
| 51 | RIPK1 | 1.15946813 |
| 52 | TNIK | 1.14842685 |
| 53 | KDR | 1.13585302 |
| 54 | LRRK2 | 1.10974896 |
| 55 | NEK1 | 1.10178131 |
| 56 | MAP2K4 | 1.09381566 |
| 57 | PBK | 1.07806851 |
| 58 | TBK1 | 1.06657018 |
| 59 | TESK1 | 1.06427628 |
| 60 | EPHA4 | 1.05512747 |
| 61 | BCR | 1.04422348 |
| 62 | NEK6 | 1.03288966 |
| 63 | BMPR2 | 0.99241120 |
| 64 | CASK | 0.98584398 |
| 65 | ERBB2 | 0.97379786 |
| 66 | MKNK2 | 0.97119855 |
| 67 | STK16 | 0.94212248 |
| 68 | EPHA3 | 0.94127980 |
| 69 | PDK2 | 0.93448426 |
| 70 | DAPK2 | 0.92232359 |
| 71 | AKT3 | 0.91548018 |
| 72 | EPHB1 | 0.91295847 |
| 73 | GRK6 | 0.91039550 |
| 74 | TGFBR2 | 0.90799775 |
| 75 | MAP3K11 | 0.89161964 |
| 76 | MAP3K10 | 0.88688683 |
| 77 | MAP2K2 | 0.87331368 |
| 78 | PRKAA2 | 0.83984091 |
| 79 | MAP3K7 | 0.83561426 |
| 80 | PRKG2 | 0.82127313 |
| 81 | JAK2 | 0.81332902 |
| 82 | PIK3CA | 0.80437656 |
| 83 | PLK1 | 0.78546456 |
| 84 | MAP2K1 | 0.75260020 |
| 85 | CDK6 | 0.74408877 |
| 86 | TIE1 | 0.74160792 |
| 87 | JAK1 | 0.69429980 |
| 88 | PDGFRA | 0.67874628 |
| 89 | MAPK4 | 0.67773890 |
| 90 | PINK1 | 0.67266673 |
| 91 | PTK2 | 0.67195342 |
| 92 | EPHB2 | 0.66198878 |
| 93 | PRKCI | 0.66080482 |
| 94 | KSR2 | 0.63880236 |
| 95 | DDR2 | 0.62786982 |
| 96 | CAMK2G | 0.60087597 |
| 97 | FER | 0.59900735 |
| 98 | LIMK1 | 0.59400321 |
| 99 | GSK3A | 0.59074479 |
| 100 | LATS2 | 0.58867038 |
| 101 | MAPK12 | 0.57525303 |
| 102 | NME1 | 0.55696148 |
| 103 | PLK4 | 0.55563973 |
| 104 | ILK | 0.54577341 |
| 105 | SIK3 | 0.54342416 |
| 106 | BRAF | 0.54148486 |
| 107 | TGFBR1 | 0.53676159 |
| 108 | TAOK2 | 0.53433181 |
| 109 | IRAK3 | 0.52404393 |
| 110 | CAMK2D | 0.51648721 |
| 111 | MKNK1 | 0.51423844 |
| 112 | PRKACG | 0.50529098 |
| 113 | STK4 | 0.49775253 |
| 114 | PHKG2 | 0.48967792 |
| 115 | PHKG1 | 0.48967792 |
| 116 | BMX | 0.48262844 |
| 117 | PRKCZ | 0.46627388 |
| 118 | MAPK15 | 0.46429006 |
| 119 | CDK19 | 0.44182445 |
| 120 | PRKAA1 | 0.44139580 |
| 121 | PAK3 | 0.43078364 |
| 122 | NUAK1 | 0.42803469 |
| 123 | FGFR1 | 0.41836270 |
| 124 | NME2 | 0.41046834 |
| 125 | DYRK1B | 0.40288083 |
| 126 | OBSCN | 0.39939674 |
| 127 | DAPK1 | 0.39847028 |
| 128 | STK3 | 0.39679624 |
| 129 | TESK2 | 0.39521455 |
| 130 | RET | 0.38442815 |
| 131 | KSR1 | 0.37423701 |
| 132 | FGFR3 | 0.37121585 |
| 133 | AKT2 | 0.35831180 |
| 134 | AURKB | 0.35545050 |
| 135 | GRK1 | 0.35528686 |
| 136 | PDPK1 | 0.34382716 |
| 137 | CLK1 | 0.34124469 |
| 138 | EIF2AK2 | 0.33772479 |
| 139 | RAF1 | 0.32704724 |
| 140 | SCYL2 | 0.32634927 |
| 141 | MINK1 | 0.32204653 |
| 142 | PAK1 | 0.31917367 |
| 143 | PAK2 | 0.31557187 |
| 144 | IGF1R | 0.31450803 |
| 145 | MAP3K2 | 0.31380288 |
| 146 | PLK2 | 0.31370101 |
| 147 | CSF1R | 0.31257880 |
| 148 | CDK4 | 0.30640182 |
| 149 | MAP3K5 | 0.29518513 |
| 150 | MAP3K8 | 0.29515237 |
| 151 | ROCK1 | 0.29447584 |
| 152 | PRKCQ | 0.29078544 |
| 153 | SGK3 | 0.28876437 |
| 154 | PRKCA | 0.28869064 |
| 155 | MAP3K14 | 0.27737746 |
| 156 | ARAF | 0.27381016 |
| 157 | STK10 | 0.27295393 |
| 158 | PAK6 | 0.26195596 |
| 159 | PIM2 | 0.25869764 |
| 160 | PRKCE | 0.25838966 |
| 161 | ALK | 0.24907199 |
| 162 | ROCK2 | 0.23785854 |
| 163 | GRK5 | 0.22807922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.98860997 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.72789640 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.47948565 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.18965089 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97706384 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.78524245 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70460561 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58823754 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.57931077 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57071066 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40389341 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35983012 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.29330985 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.17086998 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09718669 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05127147 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.99459162 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.94475939 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92824272 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92588268 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91028832 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90221196 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90189705 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88745093 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.79734839 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77334755 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69765695 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.67191374 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64295269 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59961025 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58815780 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58707215 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51294424 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51033906 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50469889 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46736940 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45629542 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.42760784 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41376859 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39833645 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36681383 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34909478 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34184668 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32610855 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31971691 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23833574 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23745784 |
| 48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.23574348 |
| 49 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.21396622 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19397929 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.18143125 |
| 52 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04484101 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.04296970 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03793482 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00096712 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97605991 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96090363 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94818546 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.94676883 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91664534 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91176333 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88633846 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85334161 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77840692 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.76600429 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75696929 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73100160 |
| 68 | Protein export_Homo sapiens_hsa03060 | 0.71644568 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71572356 |
| 70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.70082953 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69086960 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63308293 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63239300 |
| 74 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.60515608 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56227899 |
| 76 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.49683145 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49189495 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46122353 |
| 79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45121354 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45008876 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42569967 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39659593 |
| 83 | Mismatch repair_Homo sapiens_hsa03430 | 0.31452490 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.31179560 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27262249 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.26988430 |
| 87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25635233 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.24938943 |
| 89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.22358186 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.21842679 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20490011 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19902333 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.18121974 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14918608 |
| 95 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.14614101 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14526443 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13844159 |
| 98 | Huntingtons disease_Homo sapiens_hsa05016 | 0.12486891 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.11957717 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.11130421 |
| 101 | DNA replication_Homo sapiens_hsa03030 | 0.07950464 |
| 102 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.06715444 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.06662369 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.05147287 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04229654 |
| 106 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.03727649 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03426977 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03002831 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | -0.1998075 |
| 110 | Pertussis_Homo sapiens_hsa05133 | -0.1692123 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1674108 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1579049 |
| 113 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1340043 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | -0.1295211 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | -0.1281523 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1215205 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1101213 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1099327 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | -0.1097395 |
| 120 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0950844 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0935554 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0722914 |
| 123 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0630532 |
| 124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0535492 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | -0.0372010 |

